Liliana Ribeiro Santos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Liliana Ribeiro Santos has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Michael R. Ehrenstein
Department of Ageing, Rheumatology and Regenerative Medicine, University College London, UK
2 shared publications - Muhammad Shipa
Centre for Rheumatology, Division of Medicine, University College London, London, UK. Rayne Institute, 5 University St, Bloomsbury, London WC1E 6JF UK
2 shared publications Alan Salama
1 shared publication- Andrew Embleton
Comprehensive Clinical Trials Unit, University College London, London, UK
1 shared publication BEAT-LUPUS Investigators*
1 shared publicationBenjamin Parker
1 shared publication
Latest Publications
- 30 August 2022
- Published by Publicacoes Ciencia e Vida, Lda in Portuguese Journal of Nephrology & Hypertension
Beating B Cells in Lupus Nephritis
- 30 August 2022
- Published by Publicacoes Ciencia e Vida, Lda in Portuguese Journal of Nephrology & Hypertension
Beating B Cells in Lupus Nephritis
- Top Cited Papers
- 1 December 2021
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 174 (12) , 1647-1657
Effectiveness of Belimumab After Rituximab in Systemic Lupus Erythematosus
Rituximab is commonly used for patients with systemic lupus erythematosus (SLE) that is refractory to conventional therapy, but it yields variable responses. This phase 2 clinical trial sought to o... Visual Effectiveness of Belimumab After Rituximab in Systemic Lupus Erythematosus. Rituximab is commonly used for patients with systemic lupus erythematosus (SLE) that is refractory to con... Background: B-cell depletion with rituximab is commonly used for patients with systemic lupus erythematosus (SLE) that is refractory to conventional therapy, but it yields variable responses. We hy...
- 1 December 2021
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 174 (12) , 1647-1657
Top Cited PapersEffectiveness of Belimumab After Rituximab in Systemic Lupus Erythematosus
Rituximab is commonly used for patients with systemic lupus erythematosus (SLE) that is refractory to conventional therapy, but it yields variable responses. This phase 2 clinical trial sought to o... Visual Effectiveness of Belimumab After Rituximab in Systemic Lupus Erythematosus. Rituximab is commonly used for patients with systemic lupus erythematosus (SLE) that is refractory to con... Background: B-cell depletion with rituximab is commonly used for patients with systemic lupus erythematosus (SLE) that is refractory to conventional therapy, but it yields variable responses. We hy...